Requirements, features, and performance of high content screening platforms

Area of Science:

• Cell Biology
• Biotechnology
• Drug Discovery

Background:

• High content screening (HCS) integrates fluorescence microscopy, image analysis, and informatics for automated cell analysis.
• HCS applications have expanded from drug discovery screening to systems cell biology, enabling large-scale pathway and cell function studies.

Purpose of the Study:

• To discuss the requirements for HCS platforms.
• To review existing HCS systems and their suitability for various applications.
• To explore emerging trends and future developments in HCS technology.

Main Methods:

• Review of current High Content Screening (HCS) systems and their market penetration.
• Analysis of optical designs (confocal vs. wide-field) and their respective market shares.
• Evaluation of system optimization for fixed-cell versus live-cell kinetic assays.

Main Results:

• Confocal systems dominate the high-throughput HCS market; wide-field systems have a larger overall market share due to cost-effectiveness.
• While most systems are optimized for fixed cells, a growing interest in live-cell kinetic assays has led to successful market penetration by four systems.
• The HCS market has seen considerable growth in available systems and features over the past two years.

Conclusions:

• HCS platforms are increasingly vital tools in both drug discovery and systems cell biology research.
• Future HCS development will be driven by new applications, improved software, advanced data visualization, and novel detection methods like multispectral imaging and fluorescence lifetime.
• The adaptability and expanding capabilities of HCS systems suggest continued growth and innovation in the field.